Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

1.

Selective thromboxane inhibition: a new approach to antiplatelet therapy.

Fisher M, Weiner B, Ockene IS, Hoogasian JS, Natale AM, Arsenault JR, Johnson MH, Levine PH.

Stroke. 1984 Sep-Oct;15(5):813-6.

PMID:
6474531
[PubMed - indexed for MEDLINE]
Free Article
2.

A new combination therapy for selective and prolonged antiplatelet effect: results in the dog.

Kaplan S, Sauvage LR, Marcoe KF, Zammit M, Wu HD, Mathisen SR, Walker M.

Stroke. 1986 May-Jun;17(3):450-4.

PMID:
3520978
[PubMed - indexed for MEDLINE]
Free Article
3.

The biochemical pharmacology of thromboxane synthase inhibition in man.

FitzGerald GA, Reilly IA, Pedersen AK.

Circulation. 1985 Dec;72(6):1194-201. Review.

PMID:
3905048
[PubMed - indexed for MEDLINE]
4.

Effects of fenflumizole on aggregation ex vivo of human platelets and formation of thromboxane B2 and 6-keto-prostaglandin-F1 alpha.

Vinge E, Corell T, Andersson KE.

Eur J Clin Pharmacol. 1984;26(6):711-7.

PMID:
6436029
[PubMed - indexed for MEDLINE]
5.

Effect of incremental doses of aspirin on bleeding time, platelet aggregation and thromboxane production in patients with cerebrovascular disease.

Boss AH, Boysen G, Olseen JS.

Eur J Clin Invest. 1985 Dec;15(6):412-4.

PMID:
3938412
[PubMed - indexed for MEDLINE]
6.

Prostaglandins and platelet aggregation.

Smith JB.

Acta Med Scand Suppl. 1981;651:91-9.

PMID:
7034481
[PubMed - indexed for MEDLINE]
7.

Continued thromboxane A2 formation despite administration of a platelet glycoprotein IIb/IIIa antagonist in patients undergoing coronary angioplasty.

Byrne A, Moran N, Maher M, Walsh N, Crean P, Fitzgerald DJ.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):3224-9.

PMID:
9409315
[PubMed - indexed for MEDLINE]
Free Article
8.

[Low doses of acetylsalicylic acid effectively inhibits thrombocyte aggregation after ischemic stroke].

Oláh L, Misz M, Bereczki D, Fekete I, Bordánné JE, Takács EI.

Orv Hetil. 1996 Mar 3;137(9):455-9. Hungarian.

PMID:
8714038
[PubMed - indexed for MEDLINE]
9.

Platelet aggregation induced by arachidonic acid and thromboxane generation in patients with hypertension or cerebrovascular disease.

Matsumoto M, Kusunoki M, Uyama O, Fujisawa A, Matsuyama T, Yoneda S, Kimura K, Abe H.

Prostaglandins Med. 1981 Dec;7(6):553-62.

PMID:
7323212
[PubMed - indexed for MEDLINE]
10.

Synthesis and inhibitory effects of 1,4,5-trialkyl-2-thioimidazole derivatives on platelet aggregation.

Fatimi J, Lagorce JF, Chabernaud ML, Buxeraud J, Raby C.

Boll Chim Farm. 1994 Mar;133(3):151-5.

PMID:
8011274
[PubMed - indexed for MEDLINE]
11.

Effect of acetylsalicylic acid on plasma thromboxane B2 and platelet aggregation in man.

Nuotto E, Gordin A, Paasonen MK, Metsä-Ketelä T, Lamminsivu U.

Eur J Clin Pharmacol. 1983;25(3):313-7.

PMID:
6628518
[PubMed - indexed for MEDLINE]
12.

Inhibition of platelet function by low dose acetylsalicylic acid in patients with cerebrovascular disease.

Svensson J, Samuelsson K.

Thromb Res. 1983 Aug 1;31(3):499-505. No abstract available.

PMID:
20218005
[PubMed - indexed for MEDLINE]
13.

Inhibition of platelet aggregation and thromboxane synthesis by onion and garlic.

Makheia AN, Vanderhoek JY, Bailey JM.

Lancet. 1979 Apr 7;1(8119):781. No abstract available.

PMID:
86023
[PubMed - indexed for MEDLINE]
14.

Inhibition of platelet thromboxane synthesis by 7-(1-imidazolyl) heptanoic acid: dissociation from inhibition of aggregation.

Grimm LJ, Knapp DR, Senator D, Halushka PV.

Thromb Res. 1981 Nov 15;24(4):307-17. No abstract available.

PMID:
6801806
[PubMed - indexed for MEDLINE]
15.

A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.

Salvati P, Dho L, Ukmar G, Vaga L, Rimoldi O, Patrono C.

J Pharmacol Exp Ther. 1994 Apr;269(1):238-45.

PMID:
8169831
[PubMed - indexed for MEDLINE]
16.

Pyrazolinone analgesics prevent the antiplatelet effect of aspirin and preserve human platelet thromboxane synthesis.

Hohlfeld T, Zimmermann N, Weber AA, Jessen G, Weber H, Schrör K, Höltje HD, Ebel R.

J Thromb Haemost. 2008 Jan;6(1):166-73. Epub 2007 Oct 15.

PMID:
17944992
[PubMed - indexed for MEDLINE]
17.

Selective inhibition of thromboxane-related platelet function by low-dose aspirin in patients after myocardial infarction.

De Caterina R, Giannessi D, Bernini W, Gazzetti P, Michelassi C, L'Abbate A, Donato L, Patrignani P, Filabozzi P, Patrono C.

Am J Cardiol. 1985 Feb 15;55(5):589-90. No abstract available.

PMID:
3969908
[PubMed - indexed for MEDLINE]
18.

Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro.

Bode-Böger SM, Böger RH, Galland A, Frölich JC.

Naunyn Schmiedebergs Arch Pharmacol. 1998 Feb;357(2):143-50.

PMID:
9521487
[PubMed - indexed for MEDLINE]
19.

Rapid and selective inhibition of platelet aggregation and thromboxane formation by intravenous low dose aspirin in man.

Böger RH, Bode-Böger SM, Gutzki FM, Tsikas D, Weskott HP, Frölich JC.

Clin Sci (Lond). 1993 May;84(5):517-24.

PMID:
8504628
[PubMed - indexed for MEDLINE]
20.

Dose- and time-dependent antiplatelet effects of aspirin.

Perneby C, Wallén NH, Rooney C, Fitzgerald D, Hjemdahl P.

Thromb Haemost. 2006 Apr;95(4):652-8.

PMID:
16601836
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk